540 related articles for article (PubMed ID: 28356511)
1. Poly(GP) proteins are a useful pharmacodynamic marker for
Gendron TF; Chew J; Stankowski JN; Hayes LR; Zhang YJ; Prudencio M; Carlomagno Y; Daughrity LM; Jansen-West K; Perkerson EA; O'Raw A; Cook C; Pregent L; Belzil V; van Blitterswijk M; Tabassian LJ; Lee CW; Yue M; Tong J; Song Y; Castanedes-Casey M; Rousseau L; Phillips V; Dickson DW; Rademakers R; Fryer JD; Rush BK; Pedraza O; Caputo AM; Desaro P; Palmucci C; Robertson A; Heckman MG; Diehl NN; Wiggs E; Tierney M; Braun L; Farren J; Lacomis D; Ladha S; Fournier CN; McCluskey LF; Elman LB; Toledo JB; McBride JD; Tiloca C; Morelli C; Poletti B; Solca F; Prelle A; Wuu J; Jockel-Balsarotti J; Rigo F; Ambrose C; Datta A; Yang W; Raitcheva D; Antognetti G; McCampbell A; Van Swieten JC; Miller BL; Boxer AL; Brown RH; Bowser R; Miller TM; Trojanowski JQ; Grossman M; Berry JD; Hu WT; Ratti A; Traynor BJ; Disney MD; Benatar M; Silani V; Glass JD; Floeter MK; Rothstein JD; Boylan KB; Petrucelli L
Sci Transl Med; 2017 Mar; 9(383):. PubMed ID: 28356511
[TBL] [Abstract][Full Text] [Related]
2. Aberrant deposition of stress granule-resident proteins linked to C9orf72-associated TDP-43 proteinopathy.
Chew J; Cook C; Gendron TF; Jansen-West K; Del Rosso G; Daughrity LM; Castanedes-Casey M; Kurti A; Stankowski JN; Disney MD; Rothstein JD; Dickson DW; Fryer JD; Zhang YJ; Petrucelli L
Mol Neurodegener; 2019 Feb; 14(1):9. PubMed ID: 30767771
[TBL] [Abstract][Full Text] [Related]
3. Poly-GP in cerebrospinal fluid links
Lehmer C; Oeckl P; Weishaupt JH; Volk AE; Diehl-Schmid J; Schroeter ML; Lauer M; Kornhuber J; Levin J; Fassbender K; Landwehrmeyer B; ; Schludi MH; Arzberger T; Kremmer E; Flatley A; Feederle R; Steinacker P; Weydt P; Ludolph AC; Edbauer D; Otto M
EMBO Mol Med; 2017 Jul; 9(7):859-868. PubMed ID: 28408402
[TBL] [Abstract][Full Text] [Related]
4. G
Rothstein JD; Baskerville V; Rapuri S; Mehlhop E; Jafar-Nejad P; Rigo F; Bennett F; Mizielinska S; Isaacs A; Coyne AN
Acta Neuropathol; 2023 Nov; 147(1):1. PubMed ID: 38019311
[TBL] [Abstract][Full Text] [Related]
5. Antibodies inhibit transmission and aggregation of
Zhou Q; Lehmer C; Michaelsen M; Mori K; Alterauge D; Baumjohann D; Schludi MH; Greiling J; Farny D; Flatley A; Feederle R; May S; Schreiber F; Arzberger T; Kuhm C; Klopstock T; Hermann A; Haass C; Edbauer D
EMBO Mol Med; 2017 May; 9(5):687-702. PubMed ID: 28351931
[TBL] [Abstract][Full Text] [Related]
6. Drug screen in iPSC-Neurons identifies nucleoside analogs as inhibitors of (G
Czuppa M; Dhingra A; Zhou Q; Schludi C; König L; Scharf E; Farny D; Dalmia A; Täger J; Castillo-Lizardo M; Katona E; Mori K; Aumer T; Schelter F; Müller M; Carell T; Kalliokoski T; Messinger J; Rizzu P; Heutink P; Edbauer D
Cell Rep; 2022 Jun; 39(10):110913. PubMed ID: 35675776
[TBL] [Abstract][Full Text] [Related]
7. Cerebellar c9RAN proteins associate with clinical and neuropathological characteristics of C9ORF72 repeat expansion carriers.
Gendron TF; van Blitterswijk M; Bieniek KF; Daughrity LM; Jiang J; Rush BK; Pedraza O; Lucas JA; Murray ME; Desaro P; Robertson A; Overstreet K; Thomas CS; Crook JE; Castanedes-Casey M; Rousseau L; Josephs KA; Parisi JE; Knopman DS; Petersen RC; Boeve BF; Graff-Radford NR; Rademakers R; Lagier-Tourenne C; Edbauer D; Cleveland DW; Dickson DW; Petrucelli L; Boylan KB
Acta Neuropathol; 2015 Oct; 130(4):559-73. PubMed ID: 26350237
[TBL] [Abstract][Full Text] [Related]
8. Prospective natural history study of
Cammack AJ; Atassi N; Hyman T; van den Berg LH; Harms M; Baloh RH; Brown RH; van Es MA; Veldink JH; de Vries BS; Rothstein JD; Drain C; Jockel-Balsarotti J; Malcolm A; Boodram S; Salter A; Wightman N; Yu H; Sherman AV; Esparza TJ; McKenna-Yasek D; Owegi MA; Douthwright C; ; McCampbell A; Ferguson T; Cruchaga C; Cudkowicz M; Miller TM
Neurology; 2019 Oct; 93(17):e1605-e1617. PubMed ID: 31578300
[TBL] [Abstract][Full Text] [Related]
9. Suppression of mutant C9orf72 expression by a potent mixed backbone antisense oligonucleotide.
Tran H; Moazami MP; Yang H; McKenna-Yasek D; Douthwright CL; Pinto C; Metterville J; Shin M; Sanil N; Dooley C; Puri A; Weiss A; Wightman N; Gray-Edwards H; Marosfoi M; King RM; Kenderdine T; Fabris D; Bowser R; Watts JK; Brown RH
Nat Med; 2022 Jan; 28(1):117-124. PubMed ID: 34949835
[TBL] [Abstract][Full Text] [Related]
10. Disease Mechanisms of
Gendron TF; Petrucelli L
Cold Spring Harb Perspect Med; 2018 Apr; 8(4):. PubMed ID: 28130314
[TBL] [Abstract][Full Text] [Related]
11. BET bromodomain inhibitors PFI-1 and JQ1 are identified in an epigenetic compound screen to enhance C9ORF72 gene expression and shown to ameliorate C9ORF72-associated pathological and behavioral abnormalities in a C9ALS/FTD model.
Quezada E; Cappelli C; Diaz I; Jury N; Wightman N; Brown RH; Montecino M; van Zundert B
Clin Epigenetics; 2021 Mar; 13(1):56. PubMed ID: 33726839
[TBL] [Abstract][Full Text] [Related]
12. The Hairpin Form of r(G
Wang ZF; Ursu A; Childs-Disney JL; Guertler R; Yang WY; Bernat V; Rzuczek SG; Fuerst R; Zhang YJ; Gendron TF; Yildirim I; Dwyer BG; Rice JE; Petrucelli L; Disney MD
Cell Chem Biol; 2019 Feb; 26(2):179-190.e12. PubMed ID: 30503283
[TBL] [Abstract][Full Text] [Related]
13. CUG initiation and frameshifting enable production of dipeptide repeat proteins from ALS/FTD C9ORF72 transcripts.
Tabet R; Schaeffer L; Freyermuth F; Jambeau M; Workman M; Lee CZ; Lin CC; Jiang J; Jansen-West K; Abou-Hamdan H; Désaubry L; Gendron T; Petrucelli L; Martin F; Lagier-Tourenne C
Nat Commun; 2018 Jan; 9(1):152. PubMed ID: 29323119
[TBL] [Abstract][Full Text] [Related]
14. The C9orf72 repeat expansion disrupts nucleocytoplasmic transport.
Zhang K; Donnelly CJ; Haeusler AR; Grima JC; Machamer JB; Steinwald P; Daley EL; Miller SJ; Cunningham KM; Vidensky S; Gupta S; Thomas MA; Hong I; Chiu SL; Huganir RL; Ostrow LW; Matunis MJ; Wang J; Sattler R; Lloyd TE; Rothstein JD
Nature; 2015 Sep; 525(7567):56-61. PubMed ID: 26308891
[TBL] [Abstract][Full Text] [Related]
15. C9orf72 poly GA RAN-translated protein plays a key role in amyotrophic lateral sclerosis via aggregation and toxicity.
Lee YB; Baskaran P; Gomez-Deza J; Chen HJ; Nishimura AL; Smith BN; Troakes C; Adachi Y; Stepto A; Petrucelli L; Gallo JM; Hirth F; Rogelj B; Guthrie S; Shaw CE
Hum Mol Genet; 2017 Dec; 26(24):4765-4777. PubMed ID: 28973350
[TBL] [Abstract][Full Text] [Related]
16. Development of a sensitive trial-ready poly(GP) CSF biomarker assay for
Wilson KM; Katona E; Glaria I; Carcolé M; Swift IJ; Sogorb-Esteve A; Heller C; Bouzigues A; Heslegrave AJ; Keshavan A; Knowles K; Patil S; Mohapatra S; Liu Y; Goyal J; Sanchez-Valle R; Laforce RJ; Synofzik M; Rowe JB; Finger E; Vandenberghe R; Butler CR; Gerhard A; Van Swieten JC; Seelaar H; Borroni B; Galimberti D; de Mendonça A; Masellis M; Tartaglia MC; Otto M; Graff C; Ducharme S; Schott JM; Malaspina A; Zetterberg H; Boyanapalli R; Rohrer JD; Isaacs AM;
J Neurol Neurosurg Psychiatry; 2022 Jul; 93(7):761-771. PubMed ID: 35379698
[TBL] [Abstract][Full Text] [Related]
17. Targeting RNA foci in iPSC-derived motor neurons from ALS patients with a C9ORF72 repeat expansion.
Sareen D; O'Rourke JG; Meera P; Muhammad AK; Grant S; Simpkinson M; Bell S; Carmona S; Ornelas L; Sahabian A; Gendron T; Petrucelli L; Baughn M; Ravits J; Harms MB; Rigo F; Bennett CF; Otis TS; Svendsen CN; Baloh RH
Sci Transl Med; 2013 Oct; 5(208):208ra149. PubMed ID: 24154603
[TBL] [Abstract][Full Text] [Related]
18. Poly(GR) and poly(GA) in cerebrospinal fluid as potential biomarkers for C9ORF72-ALS/FTD.
Krishnan G; Raitcheva D; Bartlett D; Prudencio M; McKenna-Yasek DM; Douthwright C; Oskarsson BE; Ladha S; King OD; Barmada SJ; Miller TM; Bowser R; Watts JK; Petrucelli L; Brown RH; Kankel MW; Gao FB
Nat Commun; 2022 May; 13(1):2799. PubMed ID: 35589711
[TBL] [Abstract][Full Text] [Related]
19. C9orf72 and RAB7L1 regulate vesicle trafficking in amyotrophic lateral sclerosis and frontotemporal dementia.
Aoki Y; Manzano R; Lee Y; Dafinca R; Aoki M; Douglas AGL; Varela MA; Sathyaprakash C; Scaber J; Barbagallo P; Vader P; Mäger I; Ezzat K; Turner MR; Ito N; Gasco S; Ohbayashi N; El Andaloussi S; Takeda S; Fukuda M; Talbot K; Wood MJA
Brain; 2017 Apr; 140(4):887-897. PubMed ID: 28334866
[TBL] [Abstract][Full Text] [Related]
20. Correction of amyotrophic lateral sclerosis related phenotypes in induced pluripotent stem cell-derived motor neurons carrying a hexanucleotide expansion mutation in C9orf72 by CRISPR/Cas9 genome editing using homology-directed repair.
Ababneh NA; Scaber J; Flynn R; Douglas A; Barbagallo P; Candalija A; Turner MR; Sims D; Dafinca R; Cowley SA; Talbot K
Hum Mol Genet; 2020 Aug; 29(13):2200-2217. PubMed ID: 32504093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
